Journal of Toxicology Clinical Toxicology · 1998 · 40 citations · 12 references
PharmacyPharmacologyToxicologyPsychopharmacologySubstance Abuse ToxicologySubstance Use DisordersClinical Manifestations Of IntoxicationDesigner Drug ToxicologyDrug ToxicityDrugs Of AbuseStimulant ToxicologySubstance IntoxicationAmbient Temperature EffectsAmphetamine ToxicityDesigner Drug Overdose ManagementDirect EffectsIllicit Drug OverdoseMdma ToxicityMethamphetamine ToxicityOverdose Toxicity
INTRODUCTION: The toxicity profile of the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is well known. This designer drug is usually taken at "house parties" and may cause severe complications, sometimes leading to death, even when taken in relatively small units (1 or 2 tablets). Up to now, only a few cases of survival after ingestion of an overdose of Ecstasy have been described. In most cases the users developed hyperthermia, disseminated intravascular coagulation, rhabdomyolysis, and renal failure. CASE REPORT: We describe a man who, after ingesting 50 tablets of Ecstasy (in combination with oxazepam and alcohol) at home, recovered within 2 days. Presenting features were unconsciousness, apnea, and convulsions. It is suggested that in most cases severe 3,4-methylenedioxymethamphetamine toxicity results from an interaction between direct pharmacological effects of the drug and the prevailing environmental conditions (high ambient temperature, dancing in trance, little fluid intake).
12
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
J.A. Henry, K.J. Jeffreys, S. Dawling · The Lancet · 1992 · 736 citations
Pharmacy, Pharmacology, Toxicology +10
Clinical Management of Poisoning and Drug Overdose
Archives of Internal Medicine · 1984 · 673 citations
'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA
G Dowling · JAMA · 1987 · 301 citations
Medicine, Pharmacology, Psychiatry +14
Diane B. Miller, James P. O’Callaghan · Journal of Pharmacology and Experimental Therapeutics · 1994 · 262 citations
Medicine, Neuroscience, Pharmacology +17